Myomo, Inc.

AMEX:MYO

Medical - Devices

Healthcare
$1.25 -8.80%

-$0.13 today

Market cap
$50.12M
Beta
1.46
P/E (TTM)
-3.6
EPS (TTM)
-$0.36
52W Low $0.61High $2.68

Volume 0.21M

Average 0.62M

MYO Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Myomo, Inc.AMEX: MYO

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin widens to 68.2%

Gross margin was 68.2% in Q1 FY2026, up 1.0 pp from a year earlier. On a trailing-twelve-month basis it was 66.0%, down 5.2 pp year over year. Over 3 fiscal years it narrowed by 0.2 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
68.2%-0.3 pp QoQ
Last fiscal yearDec 2025
65.7%-5.5 pp YoY
LTMMar 2026
66.0%-5.2 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+1.0 pp——
1 year-5.5 pp——
3 years-0.2 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
65.7%
Year-over-year change
-5.5pp

Gross Margin vs competitors

How MYO compares with its peers on the latest reported figures

  • MYO's LTM Mar 2026 gross margin of 66.0% is the 3rd highest of the 4 companies compared; the peer median is 78.4%.
  • Its year-over-year change of -5.2 pp is the 3rd highest of 4, against a peer median of +2.0 pp.
  • Over three fiscal years its change of -0.2 pp compares with a peer median of -4.0 pp.
MYO Competitors Peer median
Gross Margin for MYO and competitors
Company Period LTM level YoY 3-year change
ECORelectroCore, Inc.LTM Mar 202687.2% +2.0 pp+5.6 pp
HYPDHyperion DeFi, Inc.LTM Jun 202678.4% +7425.8 pp—
MYOMyomo, Inc.LTM Mar 202666.0% -5.2 pp-0.2 pp
POCIPrecision Optics Corporation, Inc.LTM Mar 202613.8% -6.7 pp-13.6 pp
Peer median (excluding MYO) 78.4%+2.0 pp-4.0 pp

Competitors are the stored peer set for MYO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue13.86M15.56M19.24M32.55M40.93M
Cost of Revenue3.54M5.3M6.06M9.37M14.04M
Gross Profit10.31M10.25M13.18M23.19M26.89M
Gross Margin74.4%65.9%68.5%71.2%65.7%
Research & Development2.56M2.48M2.64M4.77M6.94M
Selling, General & Admin18.02M18.44M18.78M24.62M34.35M
Operating Expenses20.58M20.93M21.41M29.39M41.29M
Depreciation & Amortization335.96K542.63K517.68K776.97K1.76M
EBITDA(9.95M)(10.11M)(7.47M)(5.04M)(12.38M)
EBITDA Margin-71.8%-65.0%-38.8%-15.5%-30.2%
Operating Income(10.27M)(10.67M)(8.23M)(6.21M)(14.4M)
Operating Margin-74.1%-68.6%-42.8%-19.1%-35.2%
Interest Income1.61K88.73K410.27K388.59K476.97K
Interest Expense0000927.8K
Other Income / Expenses(15.34K)21.12K239.99K388.59K(667.51K)
Income Before Tax(10.28M)(10.65M)(7.99M)(5.82M)(15.07M)
Pre-Tax Margin-74.2%-68.5%-41.5%-17.9%-36.8%
Income Tax Expense88.93K69.94K156K365.62K504.53K
Net Income(10.37M)(10.72M)(8.15M)(6.18M)(15.57M)
Net Margin-74.9%-68.9%-42.3%-19.0%-38.1%
EPS (Basic)(1.78)(1.52)(0.28)(0.16)(0.37)
EPS (Diluted)(1.78)(1.52)(0.28)(0.16)(0.37)
Weighted Avg Shares5.83M7.05M29.1M37.76M41.86M
Weighted Avg Shares (Diluted)5.83M7.05M29.5M37.76M41.86M

Myomo, Inc.

AMEX:MYO

Intrinsic Alpha fair value

Locked

Current Price

$1.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.